Ticker

No recent analyst price targets found for HAO.

Latest News for HAO

Haoxi Health Technology Limited Announces Strategic Cooperation Framework with NOVA MEDIA to Develop An AI Digital Marketing System

BEIJING, July 14, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), a Beijing-headquartered online marketing solutions provider specializing in one-stop digital marketing services for the health and wellness industry, today announced the signing of a strategic cooperation framework agreement with NOVA MEDIA, a technology company with expertise in AI digital humans and generative AI.

GlobeNewsWire • Jul 14, 2026
Univest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)

New York, July 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of approximately $4 million for its client Haoxi Health Technology Ltd (NASDAQ: HAO) (the "Company"), a Beijing-headquartered online marketing…

Globe News Wire • Jul 13, 2026
Univest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)

New York, July 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $4 million for its client Haoxi Health Technology Ltd (NASDAQ: HAO) (the "Company"), a Beijing-headquartered online marketing…

GlobeNewsWire • Jul 13, 2026
Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering

BEIJING, July 10, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Ltd (NASDAQ: HAO) (“Haoxi” or the “Company”), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 10,000,000 of the Company's Class A Ordinary Shares, par value $0.32 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.40 per share…

GlobeNewsWire • Jul 10, 2026
Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split

BEIJING, May 19, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ: HAO; “we” or the “Company”), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.0025 per share (the “Class A Ordinary Shares”) and Class B ordinary shares, par value $0.0025 per share (the “Class B Ordinary Shares”), at a ratio of 1-for-128.

GlobeNewsWire • May 19, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for HAO.

No House trades found for HAO.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top